Wutah pendapatan taun lumaku: G1 Therapeutics, Inc. (GTHX)

Logo perusahaan publik G1 Therapeutics Inc. (GTHX)

G1 Therapeutics, Inc. (GTHX) relies on a highly scalable model: following patent registration, drug production costs decrease, thereby increasing profits. The annual revenue growth rate (rolling period) confirms this trend, where the value of 66.40 expresses the metric level. Physician confidence is based on drug safety, while streamlined logistics hubs guarantee the uninterrupted supply of oncology medications.

G1 Therapeutics (GTHX): Wutah pendapatan YoY sajrone 12 wulan kepungkur saka 11.02.2024 nganti 20.02.2024

G1 Therapeutics - rincian analitis lan metrik utama (GTHX)

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:g1therapeutics.com
Produk merek g1therapeutics.com

This indicator measures revenue dynamics over a rolling twelve-month period, reflecting the actual growth rate of income through the continuous discounting of G1 Therapeutics (GTHX) market prospects. By analyzing the year-over-year sales trajectory (TTM), an investor can assess the impact of a technological lull and the freeze of R&D programs on the fundamental stability of the business during a period of large-scale asset restructuring.

Karo sapa G1 Therapeutics, Inc. saingan

Incyte Pharma - Wutah dodolan YoY sajrone rolas wulan kepungkur|HUTCHMED Corp - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Nuvation Bio Inc.|DAWN: Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Monopar Pharma MNPR|Wutah pendapatan YoY sajrone 12 wulan kepungkur INBX|Wutah pendapatan taun lumaku I-Mab Biopharma IMAB|Wutah pendapatan YoY sajrone 12 wulan kepungkur FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Nuvectis Pharma, Inc. - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CHRS (Coherus BioSciences)|Corbus Pharma - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur CRDF (cardiffoncology.com)|BYSI: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku BioAtla Corp (BCAB)|Wutah dodolan YoY sajrone rolas wulan kepungkur Lixte Biotechnology Holdings, Inc.|CTXR: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) CLRB|Wutah dodolan YoY (TTM) BioLineRx Corporation (BLRX)|Wutah dodolan YoY sajrone rolas wulan kepungkur Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Wutah dodolan taun lumaku|KZIA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Silexion Therapeutics|NuCana plc (NCNA) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur Chimerix, Inc|Wutah pendapatan YoY sajrone 12 wulan kepungkur CYCC|KRON: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Kintara (KTRA)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Oncternal ONCT|Portage Biotech - Wutah pendapatan YoY sajrone 12 wulan kepungkur